Resident fees were $707.3 million, against $775.1 million.FacilityOperating Expensewas $503.5 million, against $567.0 million, and total average units were 42,383, against 50,012.
Fee-bearing capital reached $682 billion, up 13% over the last 12 months. The FREMarginwas 54% for the quarter and 55% over the last 12 months.
Management attributed the result to organic growth at the high end of its target range, supported by inflationary price increases, asset utilization and the commissioning of approximately $1.4 billion of capital projects from its backlog.
Sales were $1.683 billion, compared with $1.078 billion.Gross Profitwas $543.2 million, against $373.7 million, and operating profit was $453.7 million, against $322.9 million. The company said net income was significantly affected by an unrealized loss of $113.8 million onDerivativesand non-cash RINs-related items of $176.7 …
Diluted loss per share was $20.50, compared with diluted earnings of $8.34 a year earlier. Market estimates had pointed to earnings of $8.90 per share on revenue of $13.50 billion. Weighted average diluted shares were about 116.9 million, against about 136.4 million a year …
The results include theBusinesscombination with Dowlais Group Limited, for which it issued Dauch common shares valued at $933.4 million. The company said the business combination added approximately $1,310 million toCost of Goods Soldin the third quarter.
Management raised full-year 2026 Adjusted EBITDA guidance to a range of $530 million to $560 million. The board approved a distribution of $1.14 per unit, the 55th consecutive quarterly increase.
Net income was $1,152.4 million, against $194.8 million, andNet Incomeattributable to Delek was $1,133.8 million, against $178.0 million. Total diluted income per share was $18.22, compared with $2.93.
Total revenues were $374.2 million, compared with $311.8 million a year earlier. Net premiums earned were $290.7 million, against $246.3 million, and netInvestmentincome was $63.0 million, against $59.8 million.
Diluted earnings per share were $1.16, against a loss of $4.30 a year earlier, and net earnings attributable to Fluor were $158 million, against a loss of $697 million. Adjusted EPS was $0.77, compared with $0.68. The company noted that the prior-yearGAAPresults included a …